Wuguang Chang
Zhuhai, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Harnessing machine learning-driven multiomics integration: deciphering programmed cell death networks for prognostication and immunotherapy prediction in lung adenocarcinoma.
Journal: Cell biology and toxicology
Published: August 07, 2025
Comprehensive Insights Into the Role of TRPM4 in Pan-Cancer Progression and Immune Regulation.
Journal: ImmunoTargets and therapy
Published: May 22, 2025
Stimulator of interferon genes-targeted positron emission tomography tracks early microbiota-induced tumor immune remodeling and guides immunotherapy.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: April 23, 2025
Cholesterol metabolism in LUAD progression: GJB3 as a key target for cell‑based therapeutic interventions.
Journal: Molecular medicine reports
Published: February 18, 2025
The lysosome-related characteristics affects the prognosis and tumor microenvironment of lung adenocarcinoma.
Journal: Frontiers in medicine
Published: September 16, 2024
Spatial proteomic landscape of primary and relapsed hepatocellular carcinoma reveals immune escape characteristics in early relapse.
Journal: Hepatology (Baltimore, Md.)
Published: March 22, 2024
The upregulation of TGM2 is associated with poor prognosis and the shaping of the inflammatory tumor microenvironment in lung squamous cell carcinoma.
Journal: American journal of cancer research
Published: January 30, 2024
Development and validation of a disulfidptosis and disulfide metabolism-related risk index for predicting prognosis in lung adenocarcinoma.
Journal: Cancer cell international
Published: August 25, 2023
Construction and validation of a T cell proliferation regulator-related signature for predicting prognosis and immunotherapy response in lung adenocarcinoma.
Journal: Frontiers in immunology
Published: February 25, 2023
Overexpression of PSAT1 is Correlated with Poor Prognosis and Immune Infiltration in Non-Small Cell Lung Cancer.
Journal: Frontiers in bioscience (Landmark edition)
Published: February 19, 2023
PD1hi CD200hi CD4+ exhausted T cell increase immunotherapy resistance and tumour progression by promoting epithelial-mesenchymal transition in bladder cancer.
Journal: Clinical and translational medicine
Published: February 09, 2023
Last Updated: 09/26/2026